Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript February 22, 2024 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.44. KYMR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the […]
Equity Commonwealth (NYSE:EQC) Q4 2023 Earnings Call Transcript February 13, 2024 Equity Commonwealth isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and thanks for joining this call to discuss Equity Commonwealth Results for the Fourth Quarter and Full […]
Know Labs, Inc. (NYSE:KNW) Q1 2024 Earnings Call Transcript February 14, 2024 Know Labs, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Know Labs First Quarter 2024 Earnings Conference Call. Please note this conference […]